Claudia L Wong, NP
Nurse Practitioner · Santa Monica
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Providence Saint Johns Medical Foundation · 282 clinicians in this group
Hospitals listed: 557447. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Claudia L Wong’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence C19219 · Deceased
Licence status: Deceased · since 1957 · University of Louisville School of Medicine.
Licensee is deceased.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$41,926
Medicare paid this office $41,926 for 131 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 82 | $22,794 | $121 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 38 | $8,201 | $191 |
| Telephone medical discussion with physician, 21-30 minutes | 44 | $6,137 | $88 |
| Telephone medical discussion with physician, 11-20 minutes | 24 | $1,591 | $64 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 35 | $1,333 | $23 |
See all 6 services
| Long return visit (40+ min) | 82 | $22,794 | $121 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 38 | $8,201 | $191 |
| Telephone medical discussion with physician, 21-30 minutes | 44 | $6,137 | $88 |
| Telephone medical discussion with physician, 11-20 minutes | 24 | $1,591 | $64 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 35 | $1,333 | $23 |
| Principal care management services for a single high-risk disease, first 30 minutes provided personally by qualified health care professional, per calendar month. | 13 | $890 | $56 |
Who their Medicare patients are
131 Original Medicare patients in 2024. Average age 82 · 85 and older 32% · Women 63% · Health risk score 1.57. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Dementia 75% · Depression 55% · Stroke 54% · Coronary heart disease 36% · Chronic kidney disease 23% · Diabetes 21% · Atrial fibrillation 21% · Cancer 18% · Heart failure 17% · COPD 11%.
The office billed $298,819, Medicare allowed $56,073 and paid $41,926; for 429 services of 16 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 131 | 429 | 82 | 1.57 | $298,819 | $41,926 |
| 2023 | 158 | 492 | 81 | 1.34 | $269,370 | $40,138 |
| 2022 | 98 | 288 | 81 | 1.30 | $144,041 | $21,649 |
| 2021 | 93 | 320 | 81 | 1.46 | $192,681 | $28,710 |
| 2018 | 34 | 46 | 85 | 1.97 | $20,073 | $2,209 |
| 2017 | 78 | 201 | 85 | 1.73 | $65,474 | $8,006 |
| 2016 | 127 | 225 | 82 | 1.63 | $98,362 | $16,269 |
| 2015 | 144 | 280 | 82 | 1.53 | $121,234 | $24,731 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Long return visit (40+ min) | 69 | $19,702 | $132 |
| Telephone medical discussion with physician, 21-30 minutes | 62 | $7,793 | $90 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 26 | $4,998 | $185 |
| Telephone medical discussion with physician, 11-20 minutes | 33 | $2,396 | $65 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 35 | $1,677 | $23 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | 34 | $1,037 | $20 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 21 or more minutes | 12 | $523 | $35 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | 18 | $206 | $11 |
2022: 5 services
| Long return visit (40+ min) | 55 | $10,687 | $130 |
| Extended patient service without direct patient contact, first hour | 45 | $5,629 | $78 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 30 | $1,358 | $24 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | 13 | $391 | $22 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | 13 | $178 | $11 |
2021: 3 services
| Long return visit (40+ min) | 62 | $16,517 | $135 |
| Extended patient service without direct patient contact, first hour | 49 | $8,470 | $80 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 37 | $1,783 | $24 |
2018: 2 services
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 16 | $1,638 | $96 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 14 | $233 | $17 |
2017: 6 services
| Cognition and functional assessment using standardized instruments with development of recorded care plan for the patient with cognitive impairment, history obtained from patient and/or caregiver, in office or other outpatient setting or home or domiciliar | 17 | $2,157 | $127 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 33 | $1,743 | $35 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 28 | $1,165 | $23 |
| Short return visit (20+ min) | 20 | $810 | $35 |
| Return visit (30+ min) | 11 | $625 | $57 |
| Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | 20 | $588 | $19 |
2016: 4 services
| Long return visit (40+ min) | 76 | $5,925 | $76 |
| Extended office or other outpatient service, first hour | 71 | $4,672 | $65 |
| New patient visit (60+ min) | 29 | $3,409 | $118 |
| Short return visit (20+ min) | 13 | $579 | $36 |
2015: 6 services
| Extended office or other outpatient service, first hour | 75 | $5,021 | $67 |
| New patient visit (60+ min) | 36 | $4,396 | $122 |
| Extended office or other outpatient service, first hour | 59 | $4,267 | $72 |
| Long return visit (40+ min) | 38 | $3,984 | $105 |
| Long return visit (40+ min) | 47 | $3,758 | $80 |
| New patient visit (60+ min) | 21 | $3,058 | $146 |
Drugs they prescribed that Part D paid
$158,541
Pharmacies billed $158,541 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 676) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
666 generic and fewer than 11 brand-name prescriptions · $158,541 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Memantine Hcl Er | 192 | $23,396 | $122 |
| Rivastigmine | 15 | $4,666 | $311 |
| Memantine | 105 | $4,498 | $43 |
| Donepezil | 172 | $2,256 | $13 |
| Mirtazapine | 17 | $727 | $43 |
See all 8 drugs
| Memantine Hcl Er | 192 | $23,396 | $122 |
| Rivastigmine | 15 | $4,666 | $311 |
| Memantine | 105 | $4,498 | $43 |
| Donepezil | 172 | $2,256 | $13 |
| Mirtazapine | 17 | $727 | $43 |
| Escitalopram | 57 | $591 | $10 |
| Quetiapine | 35 | $505 | $14 |
| Trazodone | 14 | $222 | $16 |
Year by year
| 2024 | 676 | 155 | 0% (0) | None | $158,541 |
| 2023 | 632 | 169 | None | 3% | $167,211 |
| 2022 | 474 | 114 | 0% (0) | 4% | $49,877 |
| 2021 | 157 | 57 | 0% (0) | None | $19,388 |
| 2018 | 60 | 18 | 0% (0) | None | $8,161 |
| 2017 | 262 | 52 | 0% (0) | 19% | $25,192 |
| 2016 | 155 | 43 | None | 17% | $9,000 |
| 2015 | 142 | 51 | None | 35% | $18,605 |
| 2014 | 1,302 | 128 | 7% (86) | 19% | $120,290 |
| 2013 | 2,121 | 156 | 8% (161) | 21% | $162,822 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Memantine Hcl Er | 114 | $18,703 | $164 |
| Memantine | 103 | $6,151 | $60 |
| Rivastigmine | 12 | $5,068 | $422 |
| Donepezil | 160 | $4,150 | $26 |
| Quetiapine | 50 | $834 | $17 |
| Escitalopram | 44 | $803 | $18 |
| Duloxetine | 12 | $774 | $65 |
| Sertraline | 17 | $344 | $20 |
| Trazodone | 22 | $231 | $11 |
| Gabapentin | 11 | $222 | $20 |
2022: 11 drugs
| Memantine Hcl Er | 99 | $22,279 | $225 |
| Rivastigmine | 21 | $7,062 | $336 |
| Memantine | 80 | $6,230 | $78 |
| Donepezil | 113 | $2,853 | $25 |
| Quetiapine | 37 | $898 | $24 |
| Mirtazapine | 12 | $655 | $55 |
| Escitalopram | 16 | $316 | $20 |
| Buspirone | 16 | $179 | $11 |
| Valacyclovir | 11 | $176 | $16 |
| Trazodone | 13 | $121 | $9 |
| Sertraline | 11 | $113 | $10 |
2021: 5 drugs
| Memantine Hcl Er | 57 | $12,365 | $217 |
| Rivastigmine | 15 | $3,301 | $220 |
| Memantine | 21 | $1,041 | $50 |
| Donepezil | 25 | $467 | $19 |
| Buspirone | 11 | $122 | $11 |
2018: 1 drug
| Donepezil | 14 | $193 | $14 |
2017: 5 drugs
| Namenda Xr | 34 | $12,514 | $368 |
| Memantine | 53 | $3,258 | $61 |
| Donepezil | 70 | $769 | $11 |
| Citalopram Hbr | 15 | $172 | $11 |
| Trazodone | 11 | $75 | $7 |
2016: 5 drugs
| Namenda Xr | 15 | $4,961 | $331 |
| Memantine | 19 | $1,303 | $69 |
| Donepezil | 35 | $356 | $10 |
| Trazodone | 13 | $228 | $18 |
| Sertraline | 13 | $48 | $4 |
2015: 2 drugs
| Digoxin | 12 | $396 | $33 |
| Donepezil | 18 | $195 | $11 |
2014: 34 drugs
| Januvia | 14 | $5,298 | $378 |
| Hydrocodone-Acetaminophen | 39 | $2,740 | $70 |
| Voltaren | 22 | $1,783 | $81 |
| Mirtazapine | 48 | $768 | $16 |
| Digoxin | 17 | $761 | $45 |
| Donepezil | 33 | $628 | $19 |
| Amlodipine Besylate | 51 | $619 | $12 |
| Lisinopril | 71 | $596 | $8 |
| Omeprazole | 36 | $589 | $16 |
| Metformin | 32 | $498 | $16 |
| Losartan | 16 | $459 | $29 |
| Levothyroxine | 27 | $458 | $17 |
| Carbidopa-Levodopa | 18 | $453 | $25 |
| Acetaminophen-Codeine | 11 | $429 | $39 |
| Gabapentin | 20 | $380 | $19 |
| Simvastatin | 31 | $372 | $12 |
| Lovastatin | 28 | $362 | $13 |
| Carvedilol | 27 | $357 | $13 |
| Alendronate | 22 | $308 | $14 |
| Pantoprazole | 27 | $284 | $11 |
| Tamsulosin | 21 | $274 | $13 |
| Finasteride | 12 | $236 | $20 |
| Tramadol | 15 | $211 | $14 |
| Atenolol | 21 | $210 | $10 |
| Amox Tr-Potassium Clavulanate | 12 | $194 | $16 |
| Atorvastatin | 11 | $179 | $16 |
| Meclizine | 11 | $156 | $14 |
| Metoprolol | 24 | $141 | $6 |
| Furosemide | 37 | $136 | $4 |
| Citalopram Hbr | 17 | $135 | $8 |
| Warfarin | 12 | $133 | $11 |
| Glipizide | 17 | $96 | $6 |
| Benazepril | 14 | $92 | $7 |
| Hydrochlorothiazide | 19 | $88 | $5 |
2013: 59 drugs
| Advair Diskus | 20 | $6,488 | $324 |
| Lantus | 15 | $6,375 | $425 |
| Namenda | 15 | $6,150 | $410 |
| Cymbalta | 12 | $4,937 | $411 |
| Hydrocodone-Acetaminophen | 94 | $4,440 | $47 |
| Lidocaine | 13 | $4,041 | $311 |
| Lidoderm | 13 | $3,467 | $267 |
| Actonel | 16 | $2,732 | $171 |
| Diovan | 14 | $2,719 | $194 |
| Humalog | 12 | $2,435 | $203 |
| Fentanyl | 11 | $2,371 | $216 |
| Proair Hfa | 36 | $1,759 | $49 |
| Donepezil | 40 | $1,248 | $31 |
| Lisinopril | 122 | $1,192 | $10 |
| Omeprazole | 52 | $1,185 | $23 |
| Clotrimazole-Betamethasone | 16 | $1,022 | $64 |
| Felodipine Er | 11 | $1,008 | $92 |
| Mirtazapine | 59 | $891 | $15 |
| Amlodipine Besylate | 79 | $878 | $11 |
| Pantoprazole | 27 | $673 | $25 |
| Voltaren | 13 | $652 | $50 |
| Gabapentin | 41 | $642 | $16 |
| Amox Tr-Potassium Clavulanate | 26 | $614 | $24 |
| Levetiracetam | 11 | $586 | $53 |
| Acetaminophen-Codeine | 20 | $578 | $29 |
| Clopidogrel | 15 | $562 | $37 |
| Atorvastatin | 17 | $505 | $30 |
| Carvedilol | 35 | $486 | $14 |
| Atenolol | 30 | $428 | $14 |
| Cilostazol | 12 | $423 | $35 |
| Metformin | 34 | $413 | $12 |
| Levothyroxine | 42 | $408 | $10 |
| Quetiapine | 18 | $405 | $23 |
| Lovastatin | 22 | $388 | $18 |
| Tamsulosin | 24 | $373 | $16 |
| Potassium Chloride | 24 | $361 | $15 |
| Losartan | 13 | $335 | $26 |
| Finasteride | 16 | $334 | $21 |
| Baclofen | 21 | $320 | $15 |
| Metoprolol | 36 | $319 | $9 |
| Fluticasone Propionate | 12 | $284 | $24 |
| Oxybutynin Chloride | 20 | $281 | $14 |
| Furosemide | 55 | $280 | $5 |
| Sertraline | 18 | $267 | $15 |
| Tramadol | 15 | $254 | $17 |
| Alendronate | 19 | $250 | $13 |
| Simvastatin | 27 | $241 | $9 |
| Levofloxacin | 27 | $238 | $9 |
| Warfarin | 16 | $210 | $13 |
| Chlorthalidone | 11 | $192 | $17 |
| Haloperidol | 17 | $191 | $11 |
| Ciprofloxacin | 23 | $183 | $8 |
| Alprazolam | 12 | $173 | $14 |
| Isosorbide Mononitrate Er | 11 | $131 | $12 |
| Benazepril | 14 | $126 | $9 |
| Allopurinol | 13 | $114 | $9 |
| Hydrochlorothiazide | 16 | $91 | $6 |
| Prednisone | 16 | $77 | $5 |
| Amitriptyline | 17 | $60 | $4 |
Money from drug and device companies
$2,244 in 2025
| 2025 | 18 | 61 | None | $2,244 |
| 2024 | 11 | 31 | None | $795 |
| 2023 | 13 | 48 | None | $1,116 |
| 2022 | 8 | 11 | None | $533 |
| 2021 | 7 | 10 | None | $232 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ucb | Zilbrysq | $364 | 13 payments
|
| ACADIA Pharmaceuticals | Nuplazid | $196 | 10 payments
|
| Biogen | Leqembi | $192 | 7 payments
|
| Inspire Medical Systems | Inspire | $168 | 1 payment
|
| Neurocrine BioSciences | Ingrezza | $153 | 4 payments
|
| CSL Behring | Hizentra | $148 | 5 payments
|
See all 61 published payments
| Argenx US | Meals · 2025-12-16 | Vyvgart Hytrulo | $31 |
| CSL Behring | Meals · 2025-12-11 | Hizentra | $35 |
| Ucb | Meals · 2025-12-10 | Zilbrysq | $2 |
| Ucb | Meals · 2025-12-10 | Zilbrysq | $8 |
| Ucb | Meals · 2025-12-10 | Zilbrysq | $30 |
| ACADIA Pharmaceuticals | Meals · 2025-11-25 | Nuplazid | $11 |
| Biogen | Meals · 2025-11-18 | Leqembi | $29 |
| ACADIA Pharmaceuticals | Meals · 2025-11-10 | Nuplazid | $5 |
| ACADIA Pharmaceuticals | Meals · 2025-11-10 | Nuplazid | $28 |
| Merz Pharmaceuticals | Meals · 2025-10-29 | Inbrija | $33 |
| Ucb | Meals · 2025-10-22 | Zilbrysq | $3 |
| Ucb | Meals · 2025-10-22 | Zilbrysq | $12 |
| Ucb | Meals · 2025-10-22 | Zilbrysq | $25 |
| Eisai | Meals · 2025-10-14 | Leqembi | $113 |
| Biogen | Meals · 2025-10-12 | Leqembi | $27 |
| Alexion Pharmaceuticals | Meals · 2025-10-07 | Ultomiris | $35 |
| Ipsen Biopharmaceuticals | Meals · 2025-10-02 | Dysport | $17 |
| CSL Behring | Meals · 2025-09-25 | Hizentra | $34 |
| Eisai | Meals · 2025-09-22 | Leqembi | $22 |
| Ipsen Biopharmaceuticals | Meals · 2025-09-18 | Dysport | $23 |
| Abbvie | Meals · 2025-09-16 | Vyalev | $28 |
| Amarin Pharma | Meals · 2025-09-11 | Vascepa | $90 |
| ACADIA Pharmaceuticals | Meals · 2025-09-11 | Nuplazid | $31 |
| Ucb | Meals · 2025-09-06 | Zilbrysq | $15 |
| CSL Behring | Meals · 2025-09-05 | Hizentra | $5 |
| Biogen | Meals · 2025-08-20 | Leqembi | $28 |
| Abbvie | Meals · 2025-08-14 | Ubrelvy | $33 |
| Inspire Medical Systems | Meals · 2025-08-13 | Inspire | $168 |
| ACADIA Pharmaceuticals | Meals · 2025-08-12 | Nuplazid | $27 |
| ACADIA Pharmaceuticals | Meals · 2025-08-12 | Nuplazid | $4 |
| Neurocrine BioSciences | Meals · 2025-08-11 | Ingrezza | $36 |
| Alexion Pharmaceuticals | Meals · 2025-08-05 | Ultomiris | $32 |
| Catalyst Pharmaceuticals | Meals · 2025-07-29 | Firdapse | $23 |
| Merz Pharmaceuticals | Meals · 2025-07-22 | Xeomin | $40 |
| Tactile Systems Technology | Meals · 2025-07-15 | Flexitouch Plus | $103 |
| Neurocrine BioSciences | Meals · 2025-07-15 | Ingrezza | $39 |
| Hologic Sales and Service | Meals · 2025-07-09 | Aptima | $147 |
| Ucb | Meals · 2025-07-02 | Zilbrysq | $4 |
| Ucb | Meals · 2025-07-02 | Zilbrysq | $39 |
| Biogen | Meals · 2025-05-22 | Leqembi | $28 |
| Neurocrine BioSciences | Meals · 2025-05-20 | Ingrezza | $39 |
| ACADIA Pharmaceuticals | Meals · 2025-05-14 | Nuplazid | $4 |
| ACADIA Pharmaceuticals | Meals · 2025-05-14 | Nuplazid | $25 |
| Ipsen Biopharmaceuticals | Meals · 2025-05-06 | Dysport | $27 |
| Neurocrine BioSciences | Meals · 2025-04-28 | Ingrezza | $39 |
| CSL Behring | Meals · 2025-04-25 | Hizentra | $35 |
| CSL Behring | Meals · 2025-04-20 | Hizentra | $39 |
| Biogen | Meals · 2025-04-09 | Leqembi | $27 |
| Ipsen Biopharmaceuticals | Meals · 2025-04-09 | Dysport | $30 |
| ACADIA Pharmaceuticals | Meals · 2025-03-17 | Nuplazid | $33 |
| Amgen | Meals · 2025-03-12 | None | $124 |
| Ucb | Meals · 2025-03-05 | Rystiggo | $138 |
| Argenx US | Meals · 2025-03-04 | Vyvgart Hytrulo | $22 |
| Biogen | Meals · 2025-02-28 | Leqembi | $26 |
| Lilly USA | Meals · 2025-02-25 | Kisunla | $21 |
| ACADIA Pharmaceuticals | Meals · 2025-02-19 | Nuplazid | $29 |
| Biogen | Meals · 2025-02-13 | Leqembi | $27 |
| Argenx US | Meals · 2025-02-11 | Vyvgart Hytrulo | $30 |
| Ucb | Meals · 2025-02-05 | Zilbrysq | $34 |
| Ucb | Meals · 2025-01-30 | Zilbrysq | $8 |
| Ucb | Meals · 2025-01-30 | Zilbrysq | $46 |
See earlier years (2024, 2023, 2022, 2021)
2024: $795
| Ucb | Rystiggo | $142 | 8 payments
|
| Lilly USA | Amyvid | $140 | 6 payments
|
| ACADIA Pharmaceuticals | Nuplazid | $111 | 4 payments
|
| CSL Behring | Hizentra | $105 | 3 payments
|
| Neurocrine Biosciences | Ingrezza | $77 | 2 payments
|
| Biogen | Leqembi | $59 | 2 payments
|
| MDD US Operations | Gocovri | $49 | 2 payments
|
| Argenx US | Vyvgart Hytrulo | $31 | 1 payment
|
| Ipsen Biopharmaceuticals | Dysport | $30 | 1 payment
|
| Abbvie | Botox | $27 | 1 payment
|
| Eisai | Leqembi | $25 | 1 payment
|
2023: $1,116
| Ucb | None | $299 | 22 payments
|
| Abbott Laboratories | Infinity | $179 | 2 payments
|
| Lilly USA | Amyvid | $139 | 6 payments
|
| Neurocrine Biosciences | Ingrezza | $108 | 3 payments
|
| Lundbeck | Rexulti | $92 | 3 payments
|
| Otsuka America Pharmaceutical | Rexulti | $88 | 3 payments
|
| CSL Behring | Hizentra | $47 | 2 payments
|
| ACADIA Pharmaceuticals | Nuplazid | $37 | 2 payments
|
| Argenx US | Vyvgart Hytrulo | $33 | 1 payment
|
| Amneal Pharmaceuticals | Rytary | $30 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | None | $25 | 1 payment
|
| Eisai | Leqembi | $23 | 1 payment
|
| Averitas Pharma | Qutenza | $16 | 1 payment
|
2022: $533
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $150 | 1 payment
|
| Neurelis | Valtoco | $143 | 1 payment
|
| Scynexis | None | $81 | 1 payment
|
| Lilly USA | Amyvid | $63 | 3 payments
|
| Argenx US | Vyvgart | $37 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Gammagard | $24 | 1 payment
|
| Catalyst Pharmaceuticals | Firdapse | $22 | 1 payment
|
| CSL Behring | Hizentra | $13 | 1 payment
|
2021: $232
| Alexion Pharmaceuticals | Soliris | $64 | 2 payments
|
| Biogen | Aduhelm | $46 | 2 payments
|
| Medtronic | Percept | $37 | 2 payments
|
| Catalyst Pharmaceuticals | Firdapse | $33 | 1 payment
|
| Merz Pharmaceuticals | Xeomin | $19 | 1 payment
|
| Xeris Pharmaceuticals | Keveyis | $17 | 1 payment
|
| Acorda Therapeutics | Inbrija | $16 | 1 payment
|
Professional record
- NPI
- 1003129925
- Licence
- CA 19219California C19219: Deceased
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X)
- Mailing address
- 1313 N Milpitas Blvd Ste 265, Milpitas, CA, 95035
- NPI first listed
- 2010-07-20
- NPI last updated
- 2020-10-12
- NPI record certified
- 2020-10-12
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1313 N Milpitas Blvd Ste 265, Milpitas, CA, 95035 · 19191 S Vermont Ave, Torrance, CA, 90502